A randomized trial of hemodiafiltration and change in cardiovascular parameters

Irina M Mostovaya1, Michiel L Bots, Marinus A van den Dorpel

  • 1Department of Nephrology and, †Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands;, ‡Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands;, §Department of Nephrology,, ‖Institute for Cardiovascular Research, and, ¶Department of Cardiology, VU Medical Center, Amsterdam, The Netherlands, *Department of Nephrology, Centre Hospitalier de l'Université de Montréal, St. Luc Hospital, Montréal, Québec, Canada.

Insights

Online hemodiafiltration (HDF) did not significantly alter left ventricular mass (LVM), ejection fraction (EF), or pulse-wave velocity (PWV) compared to low-flux hemodialysis (HD) in ESRD patients. This study found no difference in cardiovascular outcomes between the two dialysis methods.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Medical Technology

Background:

  • Increased left ventricular mass (LVM), low ejection fraction (EF), and high pulse-wave velocity (PWV) are linked to mortality in end-stage renal disease (ESRD).
  • Online hemodiafiltration (HDF) is a dialysis modality that may offer cardiovascular benefits over conventional hemodialysis (HD).

Purpose of the Study:

  • To compare the effects of online HDF versus low-flux HD on LVM, EF, and PWV in ESRD patients.
  • To assess whether HDF influences key cardiovascular parameters more favorably than HD.

Main Methods:

  • A prospective study involving 342 ESRD patients (CONvective TRAnsport STudy).
  • Echocardiography used to measure LVM and EF over up to 4 years.
  • PWV measured in 189 patients over up to 3 years; analyzed using linear mixed models.

Main Results:

  • No significant differences were observed in the rate of change for LVM, EF, or PWV between the HDF and HD groups.
  • Subgroup analyses by age, sex, residual kidney function, and other factors also showed no treatment effect differences.
  • Specific changes in LVM, EF, and PWV did not differ statistically between HDF and HD treatments.

Conclusions:

  • Online HDF treatment did not demonstrate a significant effect on changes in LVM, EF, or PWV over time when compared to low-flux HD.
  • The findings suggest that HDF does not offer a distinct advantage over HD in improving these specific cardiovascular metrics in ESRD patients.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
377
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.3K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.8K